{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:19:22Z","timestamp":1792552762032,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,30]],"date-time":"2015-04-30T00:00:00Z","timestamp":1430352000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12917-015-0413-x","type":"journal-article","created":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T16:40:03Z","timestamp":1430325603000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":91,"title":["A canine-specific anti-nerve growth factor antibody alleviates pain and improves mobility and function in dogs with degenerative joint disease-associated pain"],"prefix":"10.1186","volume":"11","author":[{"given":"B Duncan X","family":"Lascelles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Knazovicky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Case","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mila","family":"Freire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F","family":"Innes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander C","family":"Drew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P","family":"Gearing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,30]]},"reference":[{"key":"413_CR1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1939-1676.2007.0014.x","volume":"22","author":"BDX Lascelles","year":"2008","unstructured":"Lascelles BDX, Gaynor JS, Smith ES, Roe SC, Marcellin-Little DJ, Davidson G, et al. Amantadine in a multimodal analgesic regimen for alleviation of refractory osteoarthritis pain in dogs. J Vet Intern Med. 2008;22:53\u20139.","journal-title":"J Vet Intern Med"},{"key":"413_CR2","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/vr.c97","volume":"166","author":"JF Innes","year":"2010","unstructured":"Innes JF, Clayton J, Lascelles BDX. Review of the safety and efficacy of long-term NSAID use in the treatment of canine osteoarthritis. Vet Rec. 2010;166:226\u201330.","journal-title":"Vet Rec"},{"key":"413_CR3","doi-asserted-by":"crossref","first-page":"514","DOI":"10.2460\/javma.230.4.514","volume":"230","author":"CL Aragon","year":"2007","unstructured":"Aragon CL, Hofmeister EH, Budsberg SC. Systematic review of clinical trials of treatments for osteoarthritis in dogs. J Am Vet Med Assoc. 2007;230:514\u201321.","journal-title":"J Am Vet Med Assoc"},{"key":"413_CR4","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/vr.164.14.418","volume":"164","author":"RO Sanderson","year":"2009","unstructured":"Sanderson RO, Beata C, Flipo R-M, Genevois J-P, Macias C, Tacke S, et al. Systematic review of the management of canine osteoarthritis. Vet Rec. 2009;164:418\u201324.","journal-title":"Vet Rec"},{"key":"413_CR5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.tips.2005.12.001","volume":"27","author":"FF Hefti","year":"2006","unstructured":"Hefti FF, Rosenthal A, Walicke PA, Wyatt S, Vergara G, Shelton DL, et al. Novel class of pain drugs based on antagonism of NGF. Trends Pharmacol Sci. 2006;27:85\u201391.","journal-title":"Trends Pharmacol Sci"},{"key":"413_CR6","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.4049\/jimmunol.168.12.6412","volume":"168","author":"K Kawamoto","year":"2002","unstructured":"Kawamoto K, Aoki J, Tanaka A, Itakura A, Hosono H, Arai H, et al. Nerve growth factor activates mast cells through the collaborative interaction with lysophosphatidylserine expressed on the membrane surface of activated platelets. J Immunol. 2002;168:6412\u20139.","journal-title":"J Immunol"},{"key":"413_CR7","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.neuint.2012.10.008","volume":"61","author":"JK Eibl","year":"2012","unstructured":"Eibl JK, Strasser BC, Ross GM. Structural, biological, and pharmacological strategies for the inhibition of nerve growth factor. Neurochem Int. 2012;61:1266\u201375.","journal-title":"Neurochem Int"},{"key":"413_CR8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pain.2005.03.039","volume":"116","author":"DL Shelton","year":"2005","unstructured":"Shelton DL, Zeller J, Ho W-H, Pons J, Rosenthal A. Nerve growth factor mediates hyperalgesia and cachexia in auto-immune arthritis. Pain. 2005;116:8\u201316.","journal-title":"Pain"},{"key":"413_CR9","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1002\/art.34385","volume":"64","author":"JR Ghilardi","year":"2012","unstructured":"Ghilardi JR, Freeman KT, Jimenez-Andrade JM, Coughlin KA, Kaczmarska MJ, Castaneda-Corral G, et al. Neuroplasticity of sensory and sympathetic nerve fibers in a mouse model of a painful arthritic joint. Arthritis Rheum. 2012;64:2223\u201332.","journal-title":"Arthritis Rheum"},{"key":"413_CR10","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1136\/annrheumdis-2012-203164","volume":"73","author":"AR Balanescu","year":"2014","unstructured":"Balanescu AR, Feist E, Wolfram G, Davignon I, Smith MD, Brown MT, et al. Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial. Ann Rheum Dis. 2014;73:1665\u201372.","journal-title":"Ann Rheum Dis"},{"key":"413_CR11","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.pain.2014.03.018","volume":"155","author":"PJ Tiseo","year":"2014","unstructured":"Tiseo PJ, Kivitz AJ, Ervin JE, Ren H, Mellis SJ. Fasinumab (REGN475), an antibody against nerve growth factor for the treatment of pain: results from a double-blind, placebo-controlled exploratory study in osteoarthritis of the knee. Pain. 2014;155:1245\u201352.","journal-title":"Pain"},{"key":"413_CR12","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/j.pain.2013.05.051","volume":"154","author":"P Sanga","year":"2013","unstructured":"Sanga P, Katz N, Polverejan E, Wang S, Kelly KM, Haeussler J, et al. Efficacy, safety, and tolerability of fulranumab, an anti-nerve growth factor antibody, in the treatment of patients with moderate to severe osteoarthritis pain. Pain. 2013;154:1910\u20139.","journal-title":"Pain"},{"key":"413_CR13","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jpain.2012.05.006","volume":"13","author":"MT Brown","year":"2012","unstructured":"Brown MT, Murphy FT, Radin DM, Davignon I, Smith MD, West CR. Tanezumab reduces osteoarthritic knee pain: results of a randomized, double-blind, placebo-controlled phase III trial. J Pain. 2012;13:790\u20138.","journal-title":"J Pain"},{"key":"413_CR14","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa0901510","volume":"363","author":"NE Lane","year":"2010","unstructured":"Lane NE, Schnitzer TJ, Birbara CA, Mokhtarani M, Shelton DL, Smith MD, et al. Tanezumab for the treatment of pain from osteoarthritis of the knee. N Engl J Med. 2010;363:1521\u201331.","journal-title":"N Engl J Med"},{"key":"413_CR15","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s40265-014-0208-6","volume":"74","author":"B Bannwarth","year":"2014","unstructured":"Bannwarth B, Kostine M. Targeting nerve growth factor (NGF) for pain management: what does the future hold for NGF antagonists? Drugs. 2014;74:619\u201326.","journal-title":"Drugs"},{"key":"413_CR16","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/1746-6148-9-226","volume":"9","author":"DP Gearing","year":"2013","unstructured":"Gearing DP, Virtue ER, Gearing RP, Drew AC. A fully caninised anti-NGF monoclonal antibody for pain relief in dogs. BMC Vet Res. 2013;9:226.","journal-title":"BMC Vet Res"},{"key":"413_CR17","doi-asserted-by":"crossref","first-page":"532","DOI":"10.2460\/ajvr.75.6.532","volume":"75","author":"RP Webster","year":"2014","unstructured":"Webster RP, Anderson GI, Gearing DP. Canine brief pain inventory scores for dogs with osteoarthritis before and after administration of a monoclonal antibody against nerve growth factor. Am J Vet Res. 2014;75:532\u20135.","journal-title":"Am J Vet Res"},{"key":"413_CR18","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.2460\/javma.241.10.1314","volume":"241","author":"MG Conzemius","year":"2012","unstructured":"Conzemius MG, Evans RB. Caregiver placebo effect for dogs with lameness from osteoarthritis. J Am Vet Med Assoc. 2012;241:1314\u20139.","journal-title":"J Am Vet Med Assoc"},{"key":"413_CR19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1532-950X.2009.00597.x","volume":"39","author":"BDX Lascelles","year":"2010","unstructured":"Lascelles BDX. Feline degenerative joint disease. Vet Surg. 2010;39:2\u201313.","journal-title":"Vet Surg"},{"key":"413_CR20","first-page":"66","volume":"77","author":"P Rialland","year":"2013","unstructured":"Rialland P, Bichot S, Lussier B, Moreau M, Beaudry F, del Castillo JRE, et al. Effect of a diet enriched with green-lipped mussel on pain behavior and functioning in dogs with clinical osteoarthritis. Can J Vet Res. 2013;77:66\u201374.","journal-title":"Can J Vet Res"},{"key":"413_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1746-6148-8-157","volume":"8","author":"A Hielm-Bjorkman","year":"2012","unstructured":"Hielm-Bjorkman A, Roine J, Elo K, Lappalainen A, Junnila J, Laitinen-Vapaavuori O. An un-commissioned randomized, placebo-controlled double-blind study to test the effect of deep sea fish oil as a pain reliever for dogs suffering from canine OA. BMC Vet Res. 2012;8:1.","journal-title":"BMC Vet Res"},{"key":"413_CR22","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/vr.102435","volume":"175","author":"MB Walton","year":"2014","unstructured":"Walton MB, Cowderoy EC, Wustefeld-Janssens B, Lascelles BDX, Innes JF. Mavacoxib and meloxicam for canine osteoarthritis: a randomised clinical comparator trial. Vet Rec. 2014;175:280.","journal-title":"Vet Rec"},{"key":"413_CR23","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/j.1939-1676.2011.00825.x","volume":"25","author":"BGJ Wernham","year":"2011","unstructured":"Wernham BGJ, Trumpatori B, Hash J, Lipsett J, Davidson G, Wackerow P, et al. Dose reduction of meloxicam in dogs with osteoarthritis-associated pain and impaired mobility. J Vet Intern Med. 2011;25:1298\u2013305.","journal-title":"J Vet Intern Med"},{"key":"413_CR24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2460\/javma.236.1.67","volume":"236","author":"JK Roush","year":"2010","unstructured":"Roush JK, Cross AR, Renberg WC, Dodd CE, Sixby KA, Fritsch DA, et al. Evaluation of the effects of dietary supplementation with fish oil omega-3 fatty acids on weight bearing in dogs with osteoarthritis. J Am Vet Med Assoc. 2010;236:67\u201373.","journal-title":"J Am Vet Med Assoc"},{"key":"413_CR25","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2460\/javma.1995.206.06.807","volume":"206","author":"PB Vasseur","year":"1995","unstructured":"Vasseur PB, Johnson AL, Budsberg SC, Lincoln JD, Toombs JP, Whitehair JG, et al. Randomized, controlled trial of the efficacy of carprofen, a nonsteroidal anti-inflammatory drug, in the treatment of osteoarthritis in dogs. J Am Vet Med Assoc. 1995;206:807\u201311.","journal-title":"J Am Vet Med Assoc"},{"key":"413_CR26","doi-asserted-by":"crossref","first-page":"e58125","DOI":"10.1371\/journal.pone.0058125","volume":"8","author":"MB Walton","year":"2013","unstructured":"Walton MB, Cowderoy E, Lascelles D, Innes JF. Evaluation of construct and criterion validity for the \u201cLiverpool osteoarthritis in dogs\u201d (LOAD) clinical metrology instrument and comparison to Two other instruments. PLoS One. 2013;8:e58125.","journal-title":"PLoS One"},{"key":"413_CR27","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.2460\/javma.233.8.1278","volume":"233","author":"DC Brown","year":"2008","unstructured":"Brown DC, Boston RC, Coyne JC. Ability of the canine brief pain inventory to detect response to treatment in dogs with osteoarthritis. J Am Vet Med Assoc. 2008;233:1278\u201383.","journal-title":"J Am Vet Med Assoc"},{"key":"413_CR28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/jvim.12004","volume":"27","author":"DC Brown","year":"2013","unstructured":"Brown DC, Boston RC, Farrar JT. Comparison of force plate gait analysis and owner assessment of pain using the canine brief pain inventory in dogs with osteoarthritis. J Vet Intern Med. 2013;27:22\u201330.","journal-title":"J Vet Intern Med"},{"key":"413_CR29","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1748-5827.2009.00765.x","volume":"50","author":"CA Hercock","year":"2009","unstructured":"Hercock CA, Pinchbeck G, Giejda A, Clegg PD, Innes JF. Validation of a client-based clinical metrology instrument for the evaluation of canine elbow osteoarthritis. J Small Animal Practice. 2009;50:266\u201371.","journal-title":"J Small Animal Practice"},{"key":"413_CR30","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/jvp.12050","volume":"36","author":"EM Cozzi","year":"2013","unstructured":"Cozzi EM, Spensley MS. Multicenter randomized prospective clinical evaluation of meloxicam administered via transmucosal oral spray in client-owned dogs. J Vet Pharmacol Ther. 2013;36:609\u201316.","journal-title":"J Vet Pharmacol Ther"},{"key":"413_CR31","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.2460\/ajvr.74.12.1467","volume":"74","author":"DC Brown","year":"2013","unstructured":"Brown DC, Bell M, Rhodes L. Power of treatment success definitions when the canine brief pain inventory is used to evaluate carprofen treatment for the control of pain and inflammation in dogs with osteoarthritis. Am J Vet Res. 2013;74:1467\u201373.","journal-title":"Am J Vet Res"},{"key":"413_CR32","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2460\/ajvr.68.5.468","volume":"68","author":"BD Hansen","year":"2007","unstructured":"Hansen BD, Lascelles BDX, Keene BW, Adams AK, Thomson AE. Evaluation of an accelerometer for at-home monitoring of spontaneous activity in dogs. Am J Vet Res. 2007;68:468\u201375.","journal-title":"Am J Vet Res"},{"key":"413_CR33","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2460\/javma.237.1.66","volume":"237","author":"DC Brown","year":"2010","unstructured":"Brown DC, Boston RC, Farrar JT. Use of an activity monitor to detect response to treatment in dogs with osteoarthritis. J Am Vet Med Assoc. 2010;237:66\u201370.","journal-title":"J Am Vet Med Assoc"},{"key":"413_CR34","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2460\/ajvr.70.4.444","volume":"70","author":"C Dow","year":"2009","unstructured":"Dow C, Michel KE, Love M, Brown DC. Evaluation of optimal sampling interval for activity monitoring in companion dogs. Am J Vet Res. 2009;70:444\u20138.","journal-title":"Am J Vet Res"},{"key":"413_CR35","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tvjl.2012.01.019","volume":"193","author":"NM Brydges","year":"2012","unstructured":"Brydges NM, Argyle DJ, Mosley JR, Duncan JC, Fleetwood-Walker S, Clements DN. Clinical assessments of increased sensory sensitivity in dogs with cranial cruciate ligament rupture. Vet J. 2012;193:545\u201350.","journal-title":"Vet J"},{"key":"413_CR36","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.tvjl.2013.10.025","volume":"199","author":"JD Briley","year":"2014","unstructured":"Briley JD, Williams MD, Freire M, Griffith EH, Lascelles BDX. Feasibility and repeatability of cold and mechanical quantitative sensory testing in normal dogs. Vet J. 2014;199:245\u201350.","journal-title":"Vet J"},{"key":"413_CR37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.tvjl.2013.11.003","volume":"199","author":"MD Williams","year":"2014","unstructured":"Williams MD, Kirkpatrick AE, Griffith E, Benito J, Hash J, Lascelles BDX. Feasibility and repeatability of thermal quantitative sensory testing in normal dogs and dogs with hind limb osteoarthritis-associated pain. Vet J. 2014;199:63\u20137.","journal-title":"Vet J"},{"key":"413_CR38","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1177\/1098612X12453904","volume":"14","author":"J Benito","year":"2012","unstructured":"Benito J, Gruen ME, Thomson A, Simpson W, Lascelles BDX. Owner-assessed indices of quality of life in cats and the relationship to the presence of degenerative joint disease. J Feline Med Surg. 2012;14:863\u201370.","journal-title":"J Feline Med Surg"},{"key":"413_CR39","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2460\/javma.233.6.925","volume":"233","author":"CM Budke","year":"2008","unstructured":"Budke CM, Levine JM, Kerwin SC, Levine GJ, Hettlich BF, Slater MR. Evaluation of a questionnaire for obtaining owner-perceived, weighted quality-of-life assessments for dogs with spinal cord injuries. J Am Vet Med Assoc. 2008;233:925\u201330.","journal-title":"J Am Vet Med Assoc"},{"key":"413_CR40","first-page":"376","volume":"4","author":"DA Gingerich","year":"2003","unstructured":"Gingerich DA, Strobel JD. Use of client-specific outcome measures to assess treatment effects in geriatric, arthritic dogs: controlled clinical evaluation of a nutraceutical. Vet Ther. 2003;4:376\u201386.","journal-title":"Vet Ther"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12917-015-0413-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-015-0413-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-015-0413-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T13:49:54Z","timestamp":1717854594000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1746-6148\/11\/101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,30]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["413"],"URL":"https:\/\/doi.org\/10.1186\/s12917-015-0413-x","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,30]]},"article-number":"101"}}